...
首页> 外文期刊>Trials >A study to assess changes in myocardial perfusion after treatment with spinal cord stimulation and percutaneous myocardial laser revascularisation; data from a randomised trial
【24h】

A study to assess changes in myocardial perfusion after treatment with spinal cord stimulation and percutaneous myocardial laser revascularisation; data from a randomised trial

机译:一项评估脊髓刺激和经皮心肌激光血管重建术治疗后心肌灌注变化的研究;来自随机试验的数据

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Spinal cord stimulation (SCS) and percutaneous myocardial laser revascularisation (PMR) are treatment modalities used to treat refractory angina pectoris, with the major aim of such treatment being the relief of disabling symptoms. This study compared the change in myocardial perfusion following SCS and PMR treatment. Methods Subjects with Canadian Cardiovascular Society class 3/4 angina and reversible perfusion defects as assessed by single-photon emission computed tomographic myocardial perfusion scintigraphy were randomised to SCS (34) or PMR (34). 28 subjects in each group underwent repeat myocardial perfusion imaging 12 months post intervention. Visual scoring of perfusion images was performed using a 20-segment model and a scale of 0 to 4. Results The mean (standard deviation) baseline summed rest score (SRS) and stress scores (SSS) were 4.6 (5.7) and 13.6 (9.0) in the PMR group and 6.1 (7.4) and 16.8 (11.6) in the SCS group. At 12 months, SRS was 5.5 (6.0) and SSS 15.3 (11.3) in the PMR group and 6.9 (8.2) and 15.1 (10.9) in the SCS group. There was no significant difference between the two treatment groups adjusted for baseline (p = 1.0 for SRS, p = 0.29 for SSS). Conclusion There was no significant difference in myocardial perfusion one year post treatment with SCS or PMR.
机译:背景技术脊髓刺激(SCS)和经皮心肌激光血运重建术(PMR)是用于治疗难治性心绞痛的治疗方式,其主要目的是缓解残疾症状。这项研究比较了SCS和PMR治疗后心肌灌注的变化。方法将加拿大心血管学会3/4级心绞痛和可逆灌注缺陷(通过单光子发射计算机断层扫描心肌灌注显像)评估的受试者随机分为SCS(34)或PMR(34)。干预后12个月,每组28位受试者进行了重复的心肌灌注显像。使用20段模型和0到4的比例对灌注图像进行视觉评分。结果平均(标准差)基线总和静止得分(SRS)和压力得分(SSS)为4.6(5.7)和13.6(9.0) )(在PMR组中)和6.1(7.4)和16.8(11.6)在SCS组中。在12个月时,PMR组的SRS为5.5(6.0),SSS为15.3(11.3),SCS组为6.9(8.2)和15.1(10.9)。调整基线的两个治疗组之间无显着差异(SRS p = 1.0,SSS p = 0.29)。结论SCS或PMR治疗后一年的心肌灌注无明显差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号